Search filters

List of works by Panos Kefalas

A price comparison of recently launched proprietary pharmaceuticals in the UK and the US

scientific article published on 12 September 2016

Annuity payments can increase patient access to innovative cell and gene therapies under England's net budget impact test

scientific article published on 31 July 2017

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

scientific article

CRP2 transcript expression pattern in embryonic chick limb

scientific article published in August 2002

Cell-based therapy technology classifications and translational challenges

scientific article

Clinical Adoption of Advanced Therapies: Challenges and Opportunities

scientific article published on 09 September 2020

Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access.

scientific article

Data collection infrastructure for patient outcomes in the UK - opportunities and challenges for cell and gene therapies launching

article

Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy

article by Panos Kefalas et al published 2018 in Journal of market access & health policy

Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom

scientific article published on 4 April 2016

Market access pathways for cell therapies in France

scientific article published on 18 November 2015

Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries

scientific article published on 15 January 2020

Reimbursement of licensed cell and gene therapies across the major European healthcare markets

scientific article published on 30 September 2015

Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion

scientific article

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease

article

Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate

scientific article published on 27 June 2019

Paulina is supported by:

About Paulina

Help